Search results

The LabUM EpiGenMed research program builds on Montpellier's internationally recognized expertise in epigenetics, (epi)genomics, and gene expression, which it aims to consolidate and extend to other fields. EpiGenMed structures collaborations between fundamental research, medical research, and training in Montpellier.  It is part of the University of Montpellier's I-SITE program of excellence and is associated with the Biology-Health cluster, in particular the Genetics-Epigenetics axis. The scientific field of LabUM EpiGenMed concerns epigenetics, epigenomics, and gene expression, with the aim of studying the determination of cell development, immune defense, and metabolism, as well as their links to pathologies. Research in these fields is evolving rapidly, and an important aspect is therefore the development of new technologies and support for their transfer to industrial players in the health sector. Actions PhD Training Networks The LabUM EpiGenMed collaborative doctoral program funds networks made up of three Montpellier research teams for the joint training of three doctoral students. Four networks have been established since 2021. Collaborative Projects LabUM EpiGenMed aims to promote collaborative projects between Montpellier research teams on topics related to genetics and epigenetics. The call for projects concerns projects that address the complexity of biological mechanisms in physiological or pathological contexts. Six projects funded to the tune of €300,000 for a period of 24 months. Proof-of-Concept Projects Proof-of-concept project funding is for emerging concepts or new technological approaches that are still at a preliminary stage and need to be consolidated. The projects are carried out collaboratively by two research teams. Six projects funded to the tune of €50,000 for a period of 24 months. Events LabUM organizes and subsidizes international events in Montpellier. Prestigious seminar series: 3-4 seminars per year featuring renowned international speakers. Call for proposals for financial support for international conferences: 12 events organized in 2023 or 2024 received between €3,000 and €10,000 in support. Workshop in Epigenetics: Annual workshop for M2 students + seminars.

BioCampus Montpellier (BCM) Biocommunication in Cardio-Metabolic Diseases (BC2M) BioCentre Lunaret Montpellier (BIOLuM) Stem Cells, Cellular Plasticity, Tissue Regeneration, and Immunotherapy of Inflammatory Diseases (IRMB) Center for the Study of Infectious Diseases and Anti-Infectious Pharmacology (CEMIPAI) Center for Structural Biology (CBS) Montpellier Center for Research Cell Biology (CRBM) Embryonic Development, Fertility and Environment (DEFE) Muscle Dynamics and Metabolism (DMEM) EuroMov Digital Health in Motion (EuroMov DHM) Génopolys Initial Management and Prevention of Acute Organ Failures in Critically Ill Patients (IMAGINE) Institute of Human Genetics (IGH) Montpellier Institute of Molecular Genetics (IGMM) Institute of Functional Genomics (IGF) Montpellier Institute of Neuroscience (INM) Montpellier Research Institute (IRCM) Montpellier Institute for Research Infectiology (IRIM) Desbrest Institute of Epidemiology and Public Health (IDESP) Bioengineering and Nanosciences Laboratory (LBN) Laboratory of Pathogens and Host Immunity (LPHI) Molecular Mechanisms in Neurodegenerative Dementias (MMDN) Pathogenesis and Control of Chronic and Emerging Infections (PCCEI) Physiology and Experimental Medicine of the Heart and Muscles (PhyMedExp) Translational Research on HIV and Endemic and Emerging Infectious Diseases (TransVIHMI) Bacterial Virulence and Chronic Infections (VBIC) Partnership Research Structures: Host-Vector-Parasite-Environment Interactions in Neglected Tropical Diseases caused by Trypanosomatids (INTERTRYP) Modeling and Engineering of Complex Biological Systems for Diagnosis (Sys2Diag)

Doctoral schools affiliated with the Biology-Health Cluster CBS2 - Chemical and Biological Sciences for Health The CBS2 doctoral school trains PhD students in all areas of Biology-Health, from drug chemistry to clinical studies, from genes to behavior. Backed by the laboratories of the Biology-Health Cluster and the Doctoral College of the University of Montpellier, it offers training by and for research and prepares future PhDs for careers in academia as well as in the private sector. CBS2 Doctoral School website SMH - Human Movement Sciences Doctoral School 463 "Human Movement Sciences" brings together the research potential of the major university centers in the Greater Southeast (Aix-Marseille, Montpellier, and Nice) in the field of human movement and its nervous, physiological, mechanical, behavioral, cognitive, and societal determinants. ED SMH website Biology and health programs University of Montpellier program website

FHU T.I.E. "Triangular analysis of interactions between host, infectious agent, and environment" Dr. A. MAKINSON (UM/CHU Montpellier) and Prof. E. TUAILLON (UM/CHU Montpellier) The TIE [taɪ] University Hospital Federation (FHU) - whose acronym refers to its generic objective of modeling human-microorganism interactions, from emergence to long-term complications, in a triangulation between host, infectious agents, and the environment—brings together stakeholders in the Montpellier-Nîmes area involved in research and care related to infectious diseases and related topics (microbiology, immunology, public health). Although the resources available to FHU are modest, these federations, which have existed in France since 2012, aim to stimulate translational research, improve the quality of care, and promote collaboration between university hospitals, research laboratories, and the private sector. Newsletter April 2024 NewsletterDownload Symposiums FHU TIE & G2i Annual Symposium: Microbiota: Between Yin and Yang - Wednesday, June 26, 2024 - Agropolis Amphitheater, 1000 Avenue Agropolis, 34394 MontpellierFHU TIE website Program available for download: FHU TIE G2i conferenceDownload Registration FHU Regenhab 2.0 "Regenerative medicine, movement modeling, and rehabilitation" Prof. C. JORGENSEN (IRMB, U1183) and Dr. A. LACAMPAGNE (Phymedex, U1046)FHU Regenhab 2.0 website FHU Evocan-2 "Immunotherapies in cancer" Prof. G. CARTRON (UM/CHU Montpellier) and Dr. N. BONNEFOY (ICM, U1194) FHU Evocan website